Anti-tumor effect of SLPI on mammary but not colon tumor growth-Reference-Cited by-同舟云学术

Anti-tumor effect of SLPI on mammary but not colon tumor growth

Published:2012-10-25 Issue:2 Volume:228 Page:469-475
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Amiano Nicolás O.,Costa María J.,Reiteri R. Macarena,Payés Cristian,Guerrieri Diego,Tateosian Nancy L.,Sánchez Mercedes L.,Maffia Paulo C.,Diament Miriam,Karas Romina,Orqueda Andrés,Rizzo Miguel,Alaniz Laura,Mazzolini Guillermo,Klein Slobodanka,Sallenave Jean-Michel,Chuluyan H. Eduardo

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcp.24153/fullpdf

Reference40 articles.

1. Demonstration of skin-derived antileukoproteinase (SKALP) and its target enzyme human leukocyte elastase in squamous cell carcinoma;Alkemade;J Pathol,1994

2. Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma;Alonso;J Surg Oncol,1996

3. Immunotherapy with SLPI over-expressing mammary tumor cells decreases tumor growth;Amiano;Cancer Immunol Immunother,2011

4. Proteins with whey-acidic-protein motifs and cancer;Bouchard;Lancet Oncol,2006

5. Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress;Cavarra;Am J Physiol Lung Cell Mol Physiol,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence;Scientific Reports;2022-07-16

2. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer;Cytokine & Growth Factor Reviews;2021-06

3. Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis;OncoImmunology;2020-01-01

4. Secretory leukocyte peptidase inhibitor expression and apoptosis effect in oral leukoplakia and oral squamous cell carcinoma;Oncology Reports;2018-02-07

5. Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers;Oncotarget;2017-11-26